Procter & Gamble Health Limited (NSE:PGHL)

Market Cap	81.02B -8.0%
Revenue (ttm)	13.49B +16.3%
Net Income	2.93B +24.1%
EPS	176.59 +24.0%
Shares Out	n/a
PE Ratio	27.60
Forward PE	25.74
Dividend	205.00 (4.22%)
Ex-Dividend Date	Feb 12, 2026

Volume	6,161
Average Volume	20,224
Open	4,900.00
Previous Close	4,874.20
Day's Range	4,838.50 - 4,918.00
52-Week Range	4,822.00 - 6,739.00
Beta	0.12
RSI	35.94
Earnings Date	Feb 6, 2026

About Procter & Gamble Health

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble H...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Employees: 1,326
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PGHL

Financial Performance

In fiscal year 2025, Procter & Gamble Health's revenue was 12.18 billion, an increase of 5.80% compared to the previous year's 11.51 billion. Earnings were 2.51 billion, an increase of 24.98%.